比较高通量血液透析与常规血液透析的临床疗效  

在线阅读下载全文

作  者:阿地拉·阿布里孜[1] 热孜万·阿布拉 岳华[1] 

机构地区:[1]新疆维吾尔自治区人民医院,新疆830000

出  处:《中华临床医师杂志(电子版)》2016年第4期2-3,共2页Chinese Journal of Clinicians(Electronic Edition)

摘  要:目的 对高通量血液透析与常规血液透析的临床疗效进行对比分析.方法 选取在我院进行血液透析的120 例患者作为本次实验的研究对象,并应用随机分组的方法将其分为对照组与观察组,对照组的患者进行常规血液透析治疗,观察组的患者给予高通量血液透析治疗,对两组患者血液透析后的血清白蛋白(ALB)、β2-微球蛋白(β2-MG)、肌酐(Cr)、血清尿素(Urea)等指标的变化情况进行对比分析.结果 血液透析后,两组患者的β2-MG、Cr、Urea 含量明显降低,对照组患者的ALB 含量明显降低,与透析前对比存在统计学差异(p〈0.05).血液透析后,研究组在β2-MG、Cr、Urea 含量下降幅度方面明显优于对照组(p〈0.05).结论 高通量血液透析能够对血液透析疾病患者进行治疗,与常规血液透析相比具有明显的优势,具备临床推广应用的价值.Objective the clinical curative effect of high flux hemodialysis and blood routine dialysis were compared. Methods a total of 120patients in our hospital hemodialysis is as the object of study and application of random grouping method of the divided into the control group and theobservation group in the control group, the patients were on regular hemodialysis treatment, patients in the observation group given high flux hemodialysistreatment, of two groups of patients after hemodialysis serum albumin (ALB), beta 2-microglobulin (2-mg), creatinine (CR), serum urea (urea) etc. refers tochanges in the underlying were compared and analyzed. Results the blood After dialysis, two groups of patients with beta 2-mg, Cr, urea content decreasedsignificantly, control group, the content of Alb decreased significantly, and pre dialysis compared to the presence of statistically significant difference (P 〈0.05). After hemodialysis, study group in beta 2-mg, Cr, urea content decline, infection rate decreased and urea clearance was significantly better than thecontrol group (P 〈 0.05). Conclusion high flux hemodialysis can for the treatment of hemodialysis patients, and routine blood dialysis compared withobvious advantages, have the value of clinical application.

关 键 词:临床疗效 高通量血液透析 常规血液透析 应用优势 

分 类 号:R459.5[医药卫生—治疗学]

 

参考文献:

正在载入数据...

 

二级参考文献:

正在载入数据...

 

耦合文献:

正在载入数据...

 

引证文献:

正在载入数据...

 

二级引证文献:

正在载入数据...

 

同被引文献:

正在载入数据...

 

相关期刊文献:

正在载入数据...

相关的主题
相关的作者对象
相关的机构对象